$HTFL

Wall Street analyst actions on Friday included Wells Fargo reiterating Nvidia as overweight and raising estimates with a $315 price target ahead of F2Q27 results. Morgan Stanley reiterated Apple and Amazon as overweight after earnings. Deutsche Bank downgraded Roblox to hold. Other calls covered SpaceX, Coinbase, Reddit, Arm, and several smaller names with new or revised ratings and targets.

HeartFlow CEO John C. Farquhar sold 22,562 shares at $27.75 each on July 10, 2026, for about $626,100, per an SEC Form 4. The sale was executed automatically under a Rule 10b5-1 plan. HeartFlow trades at about $2.3B market cap, with TTM revenue of $191.4M and a TTM net loss of $111.8M.

Farquhar John C.M. (Chief Executive Officer) sold 22,562 shares of Heartflow, Inc. (HTFL) at $27.75 ($0.63M total) on 2026-07-10 under a Rule 10b5-1 trading plan.

Farquhar John C.M. (Chief Executive Officer) sold 38,900 shares of Heartflow, Inc. (HTFL) at $35.00 ($1.36M total) on 2026-06-24 under a Rule 10b5-1 trading plan.

Heartflow, Inc. (HTFL) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. htfl-20260616x8k false 0001464521 0001464521 2026-06-16 2026-06-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ______________________ FORM 8-K ______________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Farquhar John C.M. (Chief Executive Officer) sold 22,562 shares of Heartflow, Inc. (HTFL) at $28.50 ($0.64M total) on 2026-06-10 under a Rule 10b5-1 trading plan.

Heartflow has filed a lawsuit against its competitor Cleerly, alleging misuse of AI technology in cardiology. The article is a brief news report from Reuters, distributed by Refinitiv.

This page on Stock Titan provides comprehensive details on HEARTFLOW INC (HTFL) SEC filings, including 10-K annual reports, 10-Q quarterly reports, and 8-K material event forms. It highlights the company's business as a medical technology firm using AI for coronary artery disease detection and management, and offers AI-powered summaries of complex sections. The site also includes recent insider transaction reports and conversion details for pre-IPO securities.

Heartflow, Inc. announced that its management will participate in a fireside chat at the Morgan Stanley Technology, Media & Telecom Conference on March 3, 2026. The company specializes in AI technology for coronary artery disease (CAD), having adopted its technology in over 1,400 institutions globally. Heartflow's platform transforms coronary CTA images into personalized 3D heart models, offering crucial insights without invasive procedures.

Heartflow, Inc. announced that the American College of Cardiology (ACC) and the American Heart Association (AHA) have published new scientific statements supporting the prognostic value of quantifying coronary plaque. These statements reinforce the critical role of coronary computed tomography angiography (CTA) combined with Heartflow technology in managing coronary artery disease (CAD) patients. The ACC and AHA emphasize plaque assessment for improved risk stratification and personalized, preventive treatment plans, highlighting the shift from focusing solely on artery obstruction to understanding plaque burden.